Public statements by the HIV Vaccine Trials Network (HVTN) on COVID-19

April 1, 2020

The HVTN continues to monitor the impact of COVID-19 on the conduct of the early and large-scale clinical trials we coordinate globally.

Read the statement >



March 23, 2020

In consideration of COVID—19, we are taking measures to guard the safety and welfare of all study participants and study teams who help make all our clinical trials possible.

Read the statement >